Evidence map›Paper›PMID 28846638›Full record

ArticleInternational journal of molecular sciences2017

REP1 Modulates Autophagy and Macropinocytosis to Enhance Cancer Cell Survival.

Jungwon Choi, Hyena Kim, Young Ki Bae, Heesun Cheong

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Intracellular Transport in Cancer Metabolic Reprogramming.Frontiers in cell and developmental biology · 2020
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jungwon ChoiTumor Microenvironment Research Branch, Research Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,10 Goyang-si, Gyeonggi-do 10408, Korea. 73801@ncc.re.kr.
Hyena KimTumor Microenvironment Research Branch, Research Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,10 Goyang-si, Gyeonggi-do 10408, Korea. 74490@ncc.re.kr.
Young Ki BaeTumor Microenvironment Research Branch, Research Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,10 Goyang-si, Gyeonggi-do 10408, Korea. zebra@ncc.re.kr.
Heesun CheongTumor Microenvironment Research Branch, Research Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,10 Goyang-si, Gyeonggi-do 10408, Korea. heesunch@ncc.re.kr.
National Cancer Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rab escort protein 1 (REP1), a component of the Rab geranyl-geranyltransferase 2 complex, plays a role in Rab protein recruitment in proper vesicles during vesicle trafficking. In addition to having well-known tissue degenerative phenotypes in the REP1 mutant, REP1 is tightly associated with cancer development and contributes to cell growth and survival. However, the functional mechanism of REP1 in cancer progression is largely uninvestigated. Here, we show that REP1 plays a crucial role in regulating mammalian target of rapamycin (mTOR) signaling and its downstream pathways, as well as autophagy and macropinocytosis, which are essential for cancer cell survival during metabolic stresses including starvation. REP1 small interfering RNA (siRNA) treatment downregulates mTORC1 activity in growing media, but blocks autophagosome formation under nutrient-depleted conditions. In contrast to the mild decrease of lysosomal enzyme activity seen in REP1 depletion, in REP1 knockdown the subcellular localization of lysosomes is altered, and localization of REP1 itself is modulated by intracellular nutrient levels and mTOR activity. Furthermore, REP1 depletion increases macro pinocytosis which may be a feedback mechanism to compensate autophagy inhibition. Concomitant treatment with macropinocytosis inhibitor and REP1siRNAresults in more significant cell death than autophagy blockade with REP1 knockdown. Therefore, REP1-mediated autophagy and lysosomal degradation processes act as novel regulatory mechanisms to support cancer cell survival, which can be further investigated as a potential cancer-targeting pathway.

Indexed as

AutophagyPinocytosisAdaptor Proteins, Signal TransducingAnimalsCell LineCell SurvivalDown-RegulationHeLa CellsHumansLysosomesMechanistic Target of Rapamycin Complex 1MicePancreatic NeoplasmsAdaptor Proteins, Signal TransducingCHM protein, humanMechanistic Target of Rapamycin Complex 1autophagylysosomemacropinocytosismTORC1rab escort protein 1 (REP1)

Identifiers

PMID28846638
PMCPMC5618515
OpenAlexW2747542386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.